These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 17082201

  • 1. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.
    Peleg AY, Potoski BA, Rea R, Adams J, Sethi J, Capitano B, Husain S, Kwak EJ, Bhat SV, Paterson DL.
    J Antimicrob Chemother; 2007 Jan; 59(1):128-31. PubMed ID: 17082201
    [Abstract] [Full Text] [Related]

  • 2. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S, Leavitt A, Carmeli Y.
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [Abstract] [Full Text] [Related]

  • 3. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ, Goff DA, Stevenson KB, Mangino JE.
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Chuang YC, Lin HC, Shi ZY, Kung HC, Huang CH, Tsao SM, Lu CT, Liao CH, Hsueh PR.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S, Tribuddharat C, Thamlikitkul V.
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [Abstract] [Full Text] [Related]

  • 6. Rapid development of Acinetobacter baumannii resistance to tigecycline.
    Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM.
    Pharmacotherapy; 2007 Aug; 27(8):1198-201. PubMed ID: 17655518
    [Abstract] [Full Text] [Related]

  • 7. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO.
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [Abstract] [Full Text] [Related]

  • 8. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ruzin A, Keeney D, Bradford PA.
    J Antimicrob Chemother; 2007 May; 59(5):1001-4. PubMed ID: 17363424
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA.
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E, 309 Study Group.
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ.
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P, Kim A, Nicolau DP.
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis.
    Ray L, Levasseur K, Nicolau DP, Scheetz MH.
    Ann Pharmacother; 2010 Mar; 44(3):582-6. PubMed ID: 20179255
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H, Stefanik D, Wisplinghoff H.
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract] [Full Text] [Related]

  • 19. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens.
    Poulakou G, Kontopidou FV, Paramythiotou E, Kompoti M, Katsiari M, Mainas E, Nicolaou C, Yphantis D, Antoniadou A, Trikka-Graphakos E, Roussou Z, Clouva P, Maguina N, Kanellakopoulou K, Armaganidis A, Giamarellou H.
    J Infect; 2009 Apr; 58(4):273-84. PubMed ID: 19344841
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial.
    Halstead DC, Abid J, Dowzicky MJ.
    J Infect; 2007 Jul; 55(1):49-57. PubMed ID: 17250897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.